Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Head & Neck 1Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 638Head and Neck Neoplasms 609Carcinoma, Non-Small-Cell Lung 202Thyroid Neoplasms 200Melanoma 145Nasopharyngeal Carcinoma 136Oropharyngeal Neoplasms 129Colorectal Neoplasms 129Mouth Neoplasms 128Neoplasms 113Breast Neoplasms 112Ovarian Neoplasms 105Lung Neoplasms 105Uterine Cervical Neoplasms 101Neoplasm Metastasis 93Carcinoma, Squamous Cell 86Stomach Neoplasms 84Carcinoma, Renal Cell 84Triple Negative Breast Neoplasms 79Pancreatic Neoplasms 72Esophageal Neoplasms 70Laryngeal Neoplasms 67Endometrial Neoplasms 67Urinary Bladder Neoplasms 61Sarcoma 58Prostatic Neoplasms 55Thyroid Cancer, Papillary 54Salivary Gland Neoplasms 49Carcinoma, Transitional Cell 47Carcinoma, Hepatocellular 46

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dihydropyrimidine Dehydrogenase Deficiency × Head & Neck × 1 year × Clear all
NCT04541381 2026-05-07

The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care

University of Chicago

Phase NA Suspended
860 enrolled
BreastGastrointestinalHead & Neck

Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Dihydropyrimidine Dehydrogenase Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡